CSC Financial said the medical-device sector recorded four consecutive quarters
of positive growth through Q2 2026 and posted, for the first time in four years,
a quarter of YoY growth in net profit attributable to the parent, indicating
earnings recovery. 2025 profit declines were mainly driven by IVD centralized
procurement, medical-service price adjustments, and one-off impairment charges
and FX losses at some low-value consumables firms. The firm expects the industry
to enter a new virtuous cycle as procurement effects clear, innovative products
move into commercialization, and domestic manufacturers accelerate overseas
expansion.
